Twenty-four hours after stroke, thrombocytopenic mice had significantly lower levels of circulating HMGB1 compared with mice treated with an IgG control (5.9 ± 2 ng/mL vs. 9.5 ± 2.8 ng/mL, respectively; Figure 5A). The gene discussed is HMGB1; the disease is stroke disorder.